The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Reduction of residual tumors by photodynamic diagnosis-assisted TURBT using 5-aminolevulinic acid for high-risk nonmuscle-invasive bladder cancer (BRIGHT study).
 
Taketo Kawai
No Relationships to Disclose
 
Haruki Kume
No Relationships to Disclose
 
Keiji Inoue
Honoraria - Chugai Pharma
Research Funding - SBI Pharmaceuticals
Patents, Royalties, Other Intellectual Property - SBI Pharmaceuticals
 
Kiyohide Fujimoto
Honoraria - Chugai Pharma
Research Funding - Chugai Pharma; SBI Pharmaceuticals
 
Masafumi Oyama
No Relationships to Disclose
 
Hideaki Miyake
Honoraria - Chugai Pharma
Research Funding - Chugai Pharma
 
Haruhito Azuma
No Relationships to Disclose
 
Hiroyuki Nishiyama
Honoraria - Chugai Pharma
Research Funding - Chugai Pharma
 
Nobuo Shinohara
Honoraria - Astellas Pharma; AstraZeneca; Janssen; MSD; Novartis; Ono Pharmaceutical; Pfizer; Takeda
Research Funding - Astellas Pharma (Inst); Ono Pharmaceutical (Inst)
 
Chikara Ohyama
Honoraria - Chugai Pharma
 
Takahiko Mitsui
No Relationships to Disclose
 
Atsushi Mizokami
No Relationships to Disclose
 
Mutsushi Kawakita
No Relationships to Disclose
 
Hideyasu Matsuyama
Honoraria - AstraZeneca; Bayer; Chugai Pharma; Janssen; MSD; Sanofi
Consulting or Advisory Role - Janssen; Sanofi
Research Funding - Astellas Pharma (Inst); Baxter (Inst); Bayer (Inst); Janssen (Inst); Kyowa-kirin (Inst); MSD Oncology (Inst); Pfizer (Inst); Takeda (Inst)